• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数字孪生和贝叶斯动态借用:两种最近用于纳入历史对照数据的方法。

Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data.

机构信息

Early Biometrics & Statistical Innovation, Data Science & Artificial Intelligence, R&D, AstraZeneca, Gothenburg, Sweden.

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

出版信息

Pharm Stat. 2024 Sep-Oct;23(5):611-629. doi: 10.1002/pst.2376. Epub 2024 Mar 4.

DOI:10.1002/pst.2376
PMID:38439136
Abstract

Recent years have seen an increasing interest in incorporating external control data for designing and evaluating randomized clinical trials (RCT). This may decrease costs and shorten inclusion times by reducing sample sizes. For small populations, with limited recruitment, this can be especially important. Bayesian dynamic borrowing (BDB) has been a popular choice as it claims to protect against potential prior data conflict. Digital twins (DT) has recently been proposed as another method to utilize historical data. DT, also known as PROCOVA™, is based on constructing a prognostic score from historical control data, typically using machine learning. This score is included in a pre-specified ANCOVA as the primary analysis of the RCT. The promise of this idea is power increase while guaranteeing strong type 1 error control. In this paper, we apply analytic derivations and simulations to analyze and discuss examples of these two approaches. We conclude that BDB and DT, although similar in scope, have fundamental differences which need be considered in the specific application. The inflation of the type 1 error is a serious issue for BDB, while more evidence is needed of a tangible value of DT for real RCTs.

摘要

近年来,人们越来越关注将外部对照数据纳入随机临床试验 (RCT) 的设计和评估中。这可以通过减少样本量来降低成本和缩短纳入时间。对于人口较少、招募有限的情况,这一点尤为重要。贝叶斯动态借用 (BDB) 是一种很受欢迎的选择,因为它声称可以防止潜在的先验数据冲突。数字孪生 (DT) 最近被提议作为另一种利用历史数据的方法。DT,也称为 PROCOVA™,是基于从历史对照数据构建预后评分,通常使用机器学习。该评分包含在预先指定的 ANCOVA 中作为 RCT 的主要分析。这个想法的承诺是在保证强 1 型错误控制的同时增加功效。在本文中,我们应用分析推导和模拟来分析和讨论这两种方法的示例。我们得出的结论是,BDB 和 DT,虽然在范围上相似,但存在需要在具体应用中考虑的根本差异。1 型错误的膨胀是 BDB 的一个严重问题,而对于实际的 RCT,需要更多证据证明 DT 的实际价值。

相似文献

1
Digital twins and Bayesian dynamic borrowing: Two recent approaches for incorporating historical control data.数字孪生和贝叶斯动态借用:两种最近用于纳入历史对照数据的方法。
Pharm Stat. 2024 Sep-Oct;23(5):611-629. doi: 10.1002/pst.2376. Epub 2024 Mar 4.
2
Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.贝叶斯半参数荟萃分析-预测先验在临床试验中对历史对照数据的借鉴。
Stat Med. 2021 Jun 30;40(14):3385-3399. doi: 10.1002/sim.8970. Epub 2021 Apr 13.
3
Leveraging historical data into oncology development programs: Two case studies of phase 2 Bayesian augmented control trial designs.利用历史数据促进肿瘤学开发项目:2 个 2 期贝叶斯增强控制试验设计案例研究。
Pharm Stat. 2020 May;19(3):276-290. doi: 10.1002/pst.1990. Epub 2020 Jan 5.
4
Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.将个体历史对照和综合治疗效果估计纳入贝叶斯生存试验:一项模拟研究。
BMC Med Res Methodol. 2019 Apr 24;19(1):85. doi: 10.1186/s12874-019-0714-z.
5
A novel power prior approach for borrowing historical control data in clinical trials.一种在临床试验中借用历史对照数据的新型功率先验方法。
Stat Methods Med Res. 2023 Mar;32(3):493-508. doi: 10.1177/09622802221146309. Epub 2023 Jan 4.
6
Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.独自,相聚:论贝叶斯借用法在荟萃分析中的益处
Pharm Stat. 2023 Sep-Oct;22(5):903-920. doi: 10.1002/pst.2318. Epub 2023 Jun 15.
7
Bayesian adaptive randomization design incorporating propensity score-matched historical controls.贝叶斯自适应随机化设计,结合倾向评分匹配的历史对照。
Pharm Stat. 2022 Sep;21(5):1074-1089. doi: 10.1002/pst.2203. Epub 2022 Mar 12.
8
Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.基于倾向评分的元分析预测先验,用于纳入真实世界和历史数据。
Stat Med. 2021 Sep 30;40(22):4794-4808. doi: 10.1002/sim.9095. Epub 2021 Jun 14.
9
Bayesian hypothesis testing with frequentist characteristics in clinical trials.临床试验中具有频率派特征的贝叶斯假设检验。
Contemp Clin Trials. 2019 Dec;87:105858. doi: 10.1016/j.cct.2019.105858. Epub 2019 Oct 24.
10
Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.贝叶斯动态借用不完美匹配历史对照的批判性评价。
Pharm Stat. 2020 Sep;19(5):613-625. doi: 10.1002/pst.2018. Epub 2020 Mar 17.

引用本文的文献

1
Prediction-powered inference for clinical trials: application to linear covariate adjustment.临床试验的预测驱动推理:在线性协变量调整中的应用。
BMC Med Res Methodol. 2025 Aug 29;25(1):204. doi: 10.1186/s12874-025-02647-6.
2
Treatment Comparison for a Single Arm Study Utilizing External Control: Performing Inference when Imputing Potential Outcomes.利用外部对照的单臂研究的治疗比较:在推算潜在结果时进行推断
Ther Innov Regul Sci. 2025 Jul 22. doi: 10.1007/s43441-025-00839-2.
3
Prediction-powered Inference for Clinical Trials.临床试验的预测驱动推理
medRxiv. 2025 Jan 18:2025.01.15.25320578. doi: 10.1101/2025.01.15.25320578.
4
Bayesian analysis of the rate of spontaneous malignant mesothelioma among BAP1 mutant mice in the absence of asbestos exposure.在无石棉暴露情况下对BAP1突变小鼠自发性恶性间皮瘤发生率的贝叶斯分析。
Sci Rep. 2025 Jan 2;15(1):169. doi: 10.1038/s41598-024-84069-w.
5
Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups.用于评估生物标志物阳性和阴性亚组中差异效应的贝叶斯解决方案。
Pharm Stat. 2025 Mar-Apr;24(2):e2456. doi: 10.1002/pst.2456. Epub 2024 Nov 25.